Xin, Qianqian
Wu, Qianhui
Chen, Xinhua
Han, Bihua
Chu, Kai
Song, Yan
Jin, Hui
Chen, Panpan
Lu, Wanying
Yang, Tuantuan
Li, Minjie http://orcid.org/0000-0002-6830-5658
Zhao, Yuliang http://orcid.org/0000-0002-2160-8870
Pan, Hongxing http://orcid.org/0000-0002-3791-1241
Yu, Hongjie http://orcid.org/0000-0002-6335-5648
Wang, Lin http://orcid.org/0000-0002-2571-4320
Article History
Received: 24 January 2022
Accepted: 24 May 2022
First Online: 3 June 2022
Competing interests
: H.Y. has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, and Shanghai Roche Pharmaceutical Company. None of those research funding is related to the development of COVID-19 vaccines. Q.X. and T.Y. were the employees of Sinovac Biotech Ltd., L.W. was an employee of Sinovac Life Sciences Co., Ltd. The remaining authors declare no competing interests.